Publication | Open Access

The RXR agonist LG100268 causes hepatomegaly, improves glycaemic control and decreases cardiovascular risk and cachexia in diabetic mice suffering from pancreatic beta-cell dysfunction

Metabolic SyndromeDiabetes ManagementMedicinePhysiologyDiabetesDiabetic MicePancreatic Beta-cell DysfunctionRxr Agonist Lg100268Diabetes MellitusEndocrinologyPharmacologyCell SignalingHealth Sciences